| dc.contributor.author | Vareldzis, Basil P | en |
| dc.contributor.author | Grosset, Jacques | en |
| dc.contributor.author | Crofton, Sir John | en |
| dc.contributor.author | Laszlo, Adalbert | en |
| dc.contributor.author | Felten, Michael | en |
| dc.contributor.author | Raviglione, Mario C | en |
| dc.contributor.author | Kochi, Arata | en |
| dc.contributor.author | Kantor, Isabel N. de | en |
| dc.date.accessioned | 2012-06-16T16:40:17Z | |
| dc.date.available | 2012-06-16T16:40:17Z | |
| dc.date.created | 1994 | en |
| dc.date.issued | 1994 | en |
| dc.identifier.uri | https://iris.who.int/handle/10665/52370 | |
| dc.subject.mesh | Antitubercular Agents | en |
| dc.subject.mesh | Mycobacterium tuberculosis | en |
| dc.subject.mesh | Tuberculosis, Multidrug-Resistant | en |
| dc.subject.other | Communicable Diseases and their Control | en |
| dc.title | Drug-resistant tuberculosis : laboratory issues, World Health Organization recommendations / B. P. Vareldzis ... [et al.] | en |
| dc.type | Journal / periodical articles | |
| dc.subject.meshqualifier | pharmacology | en |
| dc.subject.meshqualifier | drug effects | en |
| dc.subject.meshqualifier | drug therapy | en |
| dc.relation.ispartofjournal | Tubercle and lung disease 1994 ; 75(1) : 1-7 | |
